- Initiating ART in persons newly diagnosed with HIV infection
- Modifying ART for a person with HIV and stable virologic suppression on ART
- Key considerations for persons with HIV with long-term experience on ART
Question and Answer Session
Date / Time
Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Princy Kumar, MD
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Timothy Wilkin, MD
Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Cornell Medical College
New York, New York
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.
- Integrate best practices when selecting first-line ARV regimens for HIV-infected patients
- Apply appropriate treatment modification strategies for patients already receiving ART who are virologically suppressed
- Distinguish among best strategies to employ with patients who are highly treatment experienced
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this activity is 2.5 contact hours.
Pharmacist Continuing Education
CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-021-L02-P.
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.